Corona Remedies acquires Wokadine® brand from Dr. Reddy's Laboratories, marking its fifth inorganic acquisition, effective March 30, 2026.
Wokadine® is ranked #2 in India's INR 648 Cr Povidone Iodine market with 14 SKUs across multiple clinical applications.
The acquisition is fully funded through internal accruals and cash; financial terms of the deal were not disclosed.